Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Outset Medical, Inc. OM
$19.81
-$0.38 (-1.93%)
На 18:03, 12 мая 2023
+36.29%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
981496678.00000000
-
week52high
30.55
-
week52low
11.41
-
Revenue
115375000
-
P/E TTM
-18
-
Beta
1.48095900
-
EPS
-3.60000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 10:59
Описание компании
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Buy | Buy | 03 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 02 авг 2022 г. |
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Overweight | 14 июл 2022 г. |
| Stifel | Buy | Buy | 14 июн 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 окт 2022 г. |
| RBC Capital | Outperform | 11 ноя 2022 г. | |
| Morgan Stanley | Equal-Weight | Equal-Weight | 10 ноя 2022 г. |
| Goldman Sachs | Buy | Buy | 09 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Trigg Leslie | D | 40508 | 30000 | 01 февр 2023 г. |
| Trigg Leslie | D | 414044 | 30000 | 01 февр 2023 г. |
| Trigg Leslie | A | 444044 | 30000 | 01 февр 2023 г. |
| Williamson Steven S. | D | 127165 | 3023 | 27 янв 2023 г. |
| Trigg Leslie | D | 414044 | 6281 | 27 янв 2023 г. |
| Vazquez Martin | D | 104435 | 4674 | 27 янв 2023 г. |
| Ahmed Nabeel | D | 96909 | 4938 | 27 янв 2023 г. |
| Brottem John L. | D | 67780 | 4282 | 27 янв 2023 г. |
| Porter Stacey L. | D | 64535 | 2295 | 27 янв 2023 г. |
| Racine Jean-Olivier | D | 79288 | 2066 | 27 янв 2023 г. |
Новостная лента
Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023
Business Wire
25 янв 2023 г. в 08:30
SAN JOSE, Calif.--( BUSINESS WIRE )--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2022 after the close of trading on Monday, February 13, 2023.
Why Outset Medical's Shares Rose 22.5% in December
The Motley Fool
03 янв 2023 г. в 18:10
Improved guidance and a big contract attracted investors to the dialysis equipment company.
Supercharged Returns: 2 Growth Stocks That Could Turn $1,000 Into $10,000
The Motley Fool
23 дек 2022 г. в 05:20
Little-known Boston Omaha is a quiet compounder, while Outset Medical's dialysis treatment could change millions of lives.
Outset Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
Business Wire
20 дек 2022 г. в 16:05
SAN JOSE, Calif.--( BUSINESS WIRE )--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 11:15am PT / 2:15pm ET.
Outset Medical: Revising To Buy, Market Dynamics, Guidance As Catalysts (Upgrade)
Seeking Alpha
06 дек 2022 г. в 15:23
Outset Medical, Inc. revised FY22 guidance to the upside, with management forecasts now ahead of consensus. Home hemodialysis market is poised for ongoing growth into 2028.